240 results
Page 6 of 12
6-K
EX-99
bj58mjns5bkqvzk3zb5
12 Mar 20
BioLineRx Reports Year-End 2019 Financial Results
7:00am
6-K
EX-99
yx33dht
30 Jan 20
Extraordinary General Meeting of Shareholders
7:00am
6-K
EX-99
3yyu6jhsfef
13 Dec 19
BioLineRx Announces Updated Phase 2a Data from Triple
7:00am
6-K
EX-1
t7n17mkugl68noj8v3l
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-3
iriveql402uppb
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
5s2ph6 pu1
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
3udcphby14o xk8ml
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-1
n1igbsjg 0uljx
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
236ndmu70fzvc4
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
nsrphd gouyk
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
l0jeqv8tqpx8civ wlai
28 Mar 19
BioLineRx Reports Year End 2018 Financial Results
7:00am
6-K
EX-99
17pjs1etuq3oh kokmtk
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
6pydlq5408kmr7i
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
6481rc7
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99
lw0x7kv
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
u4qf2wknv oy9a90
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99.1
nf6v2obe
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
jfon5khgb8mvy al16f
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
0igbyxzt8hugrxwh
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am